Schizophrenia Statistics & Facts: How Common is it?

October 2, 2023
Schizophrenia is a complex mental health disorder associated with co-occurring conditions, an increased risk of premature death, and more.
Schizophrenia Statistics & Facts: How Common is it?

Schizophrenia is a complex and severe mental illness that can have a significant impact on a person's life. It can cause delusions, hallucinations, disordered thinking, and abnormal movements. Although we don't know the exact cause of schizophrenia, researchers have identified several risk factors, including genetics, environmental factors, and brain chemistry.

Even with advances in treatment, schizophrenia is still a major cause of disability worldwide and puts a financial burden on individuals, families, and society as a whole.

Key Schizophrenia Statistics & Facts

  1. Schizophrenia affects an estimated 20 million people worldwide.
  2. Onset of the illness typically occurs in the late teenage years or early adulthood.
  3. Men and women are affected equally.
  4. Schizophrenia is among the top 10 causes of disability worldwide.
  5. Roughly 25% of people with schizophrenia recover completely, while 50% experience significant improvement in their symptoms.
  6. Approximately 10% of people with schizophrenia die by suicide.
  7. The lifetime prevalence of substance abuse among people with schizophrenia is approximately 50%.
  8. Schizophrenia is associated with a higher risk of cardiovascular disease, diabetes, and obesity.
  9. People with schizophrenia are more likely to be unemployed and have lower income levels than the general population.
  10. Schizophrenia places a significant financial burden on individuals, families, and society as a whole.

Schizophrenia: How common is it?

Source: psychnews.psychiatryonline.org
  • Schizophrenia affects about 1% of the world's population, regardless of culture, gender or socioeconomic status.
  • In the United States, approximately 3.2 million people have schizophrenia.
  • It is estimated that around 100,000 young people experience their first episode of psychosis each year in the United States alone.
  • Schizophrenia is more commonly diagnosed in men than women and tends to develop at an earlier age in men.
  • The risk of developing schizophrenia increases if a family member has the disorder. People with a first-degree relative with schizophrenia are ten times more likely to develop the disorder than those without a family history.
  • Studies suggest that ethnic minorities may be at higher risk for schizophrenia due to factors such as discrimination and lack of access to healthcare.

Schizophrenia Statistics in the U.S.

  • Schizophrenia affects approximately 1.1% of adults in the United States each year.
  • In the United States, about 3.5 million people are diagnosed with schizophrenia.
  • Schizophrenia is more commonly diagnosed in men than women in the US.
  • The prevalence of schizophrenia varies among different racial and ethnic groups, with African Americans having a higher incidence rate than any other group in the US.
  • Around 40% of people with schizophrenia in the US do not receive appropriate treatment for their condition.
  • The annual cost of schizophrenia in the United States exceeds $155 billion, including both direct medical costs and indirect costs such as lost productivity and unemployment.

Schizophrenia Prevalence by Country

Schizophrenia statistics vary by country, with some countries having higher rates of the disorder than others. Here are some statistics on schizophrenia prevalence in different countries:

  • Japan: 0.7%
  • United Kingdom: 1%
  • Canada: 1.1%
  • United States: 1.1%
  • Australia: 1.2%
  • Switzerland: 2%

It's important to note that these statistics may not be entirely accurate due to differences in diagnostic criteria and data collection methods across countries.

Schizophrenia Prevalence by Age, Gender and Race/Ethnicity

Characteristic Prevalence
Age of onset 16-30 years old
Average age of onset by gender Men: 18 years old
Women: 25 years old
Gender prevalence Higher in men until age 45, then more equal between genders
Race/ethnicity prevalence African Americans have highest incidence rate, followed by Hispanic Americans. Asian Americans have lowest incidence rate.
Immigration status prevalence Higher risk among first-generation immigrants compared to second-generation immigrants or those born in their home country.
  • Schizophrenia is typically diagnosed in individuals between the ages of 16 and 30.
  • Men are more likely to develop schizophrenia at an earlier age than women, with the average age of onset being 18 for men and 25 for women.
  • The prevalence of schizophrenia is higher in men than women until the age of 45, after which it becomes more equal between genders.
  • African Americans have a higher incidence rate of schizophrenia than any other racial/ethnic group in the US, followed by Hispanic Americans.
  • Asian Americans have a lower incidence rate of schizophrenia compared to other groups.
  • The risk of developing schizophrenia is higher among first-generation immigrants compared to second-generation immigrants or those born in their home country.

Schizophrenia Onset: Age, Gender, and Trauma

  • The age of onset for schizophrenia is typically in the late teenage years or early adulthood, with most individuals experiencing their first episode between the ages of 16 and 30.
  • However, it's important to note that schizophrenia can develop at any age, including childhood and later in life.
  • In men, the average age of onset is typically earlier than in women, with an average age of 18 compared to 25 for women.
  • The prevalence of schizophrenia is higher in men than women until the age of 45, after which it becomes more equal between genders.
  • Studies suggest that there may be a link between early childhood trauma and a younger age of onset for schizophrenia.
  • Additionally, substance abuse during adolescence has been shown to increase the risk and accelerate the onset of schizophrenia.

Co-occurring Disorders in Schizophrenia

  • Schizophrenia is commonly associated with co-occurring mental health disorders. According to a study by the National Institute of Mental Health, approximately 50% of individuals with schizophrenia also have a co-occurring substance use disorder.
  • Depression is another common co-occurring disorder in individuals with schizophrenia. The same study found that around 25% of people with schizophrenia also experience depression.
  • Anxiety disorders are also prevalent among individuals with schizophrenia. A review published in the journal Schizophrenia Research estimated that around 20% of people with schizophrenia also have an anxiety disorder.
  • Bipolar disorder is another mental health condition that can co-occur with schizophrenia. The same review found that approximately 10% of people with schizophrenia also have bipolar disorder.

Schizophrenia Risk Factors

  • Schizophrenia risk factors include genetics, environmental factors, brain chemistry, and substance abuse.
  • Studies suggest that if a person has a first-degree relative with schizophrenia, their likelihood of developing the disorder increases by around 10 times.
  • Other risk factors for schizophrenia include prenatal exposure to infection or malnutrition, childhood trauma, and living in an urban environment.
  • Substance abuse is also a significant risk factor for developing schizophrenia and can accelerate the onset of symptoms.
  • Approximately 50% of people with schizophrenia have a co-occurring substance use disorder.

Mortality Risk for Individuals with Schizophrenia

Source: semanticscholar.org
  • Individuals with schizophrenia are at an increased risk for premature death.
  • The average lifespan of individuals with schizophrenia is estimated to be 10-20 years shorter than those without the disorder.
  • Suicide accounts for approximately 10% of deaths related to schizophrenia.
  • Other causes of death among individuals with schizophrenia include cardiovascular disease, respiratory disease, and infectious diseases.
  • Studies suggest that individuals with schizophrenia have a higher risk of dying from COVID-19 compared to the general population.

Schizophrenia Treatment: Facts and Statistics

  • Approximately 60% of people with schizophrenia do not receive adequate treatment for their condition. (National Alliance on Mental Illness)
  • The most common form of treatment for schizophrenia is antipsychotic medication, which can help reduce symptoms such as hallucinations and delusions. (National Institute of Mental Health)
  • Cognitive behavioral therapy (CBT) has been shown to be an effective adjunct to medication for treating schizophrenia. (Schizophrenia Research)
  • Electroconvulsive therapy (ECT) may be used in cases where medication and psychotherapy have been ineffective. (Mayo Clinic)
  • Long-term adherence to treatment is a major challenge for individuals with schizophrenia, with approximately 50% of people discontinuing their medication within the first year of treatment. (Psychiatric Times)

Treatment Types for Schizophrenia

  • Antipsychotic medication is the most common form of treatment for schizophrenia, with approximately 70% of individuals with schizophrenia taking antipsychotic medication.
  • Cognitive behavioral therapy (CBT) has been shown to be effective in reducing symptoms and improving quality of life for individuals with schizophrenia, with one study finding that CBT led to a 50% reduction in symptom severity.
  • Family therapy can also be an effective treatment for schizophrenia, as it can help improve communication and reduce stress among family members. One study found that family therapy led to a significant reduction in relapse rates among individuals with schizophrenia.
  • Supported Employment is a specialized program designed to help people with mental illness, including schizophrenia, find and maintain employment. Studies have shown that Supported Employment programs can lead to higher rates of employment and job retention among individuals with schizophrenia compared to traditional vocational rehabilitation programs.

What are the Healthcare Costs of Schizophrenia?

Cost Amount
Annual cost of schizophrenia in the US $155 billion
Percentage of total healthcare costs accounted for by hospitalization Approximately 50%
Lifetime cost of caring for an individual with schizophrenia $2 million
Average wholesale price for one-month supply of a second-generation antipsychotic medication Over $1,000
Total economic burden of schizophrenia in the US annually Over $60 billion
  • The annual cost of schizophrenia in the United States exceeds $155 billion, including both direct medical costs and indirect costs such as lost productivity and unemployment. (National Institute of Mental Health)
  • Individuals with schizophrenia are more likely to require hospitalization, which can be a significant expense. According to one study, hospitalization accounts for approximately 50% of total healthcare costs for individuals with schizophrenia. (Journal of Psychiatric Practice)
  • Long-term care for individuals with schizophrenia can also be expensive. One study estimated that the lifetime cost of caring for an individual with schizophrenia is approximately $2 million. (Schizophrenia Research)
  • The cost of medication can also be a significant burden for individuals with schizophrenia. In 2018, the average wholesale price for a one-month supply of a second-generation antipsychotic medication was over $1,000. (Medscape)
  • The financial burden of schizophrenia extends beyond healthcare costs and includes lost productivity due to unemployment or underemployment. One study estimated that the total economic burden of schizophrenia in the United States is over $60 billion annually. (Psychiatric Services)

Little-Known Facts About Schizophrenia

  • Approximately 7.5% of people with schizophrenia attempt suicide, and around 4% die by suicide.
  • People with schizophrenia are more likely to smoke cigarettes than the general population, with rates estimated to be as high as 90%.
  • The unemployment rate among people with schizophrenia is estimated to be around 70%, and those who are employed often work in low-paying jobs.
  • People with schizophrenia have a higher risk of homelessness, with up to one-third of homeless individuals having a serious mental illness like schizophrenia.
  • The average life expectancy for people with schizophrenia is approximately 15 years lower than the general population.

To Recap

Schizophrenia is a serious and complex mental health disorder affecting about 1% of the world's population. It typically develops in late teenage years or early adulthood, with men having an earlier age of onset than women.

Family history, prenatal exposure to infection or malnutrition, childhood trauma and substance abuse are among the major risk factors for developing schizophrenia. The disorder is associated with co-occurring mental health issues like substance abuse, depression, anxiety disorders and bipolar disorder.

Schizophrenia places a significant financial burden on individuals, families and society as a whole - the annual cost of schizophrenia in the United States alone exceeds $155 billion. While antipsychotic medication is the most common form of treatment for schizophrenia, cognitive behavioral therapy (CBT), family therapy and Supported Employment programs can also be effective treatment options. Despite advances in treatment options, approximately 60% of people with schizophrenia still do not receive adequate treatment for their condition.

Sources

  • World Health Organization. (2019). Schizophrenia. Retrieved from https://www.who.int/mental_health/management/schizophrenia/en/
  • National Institute of Mental Health. (2021). Schizophrenia. Retrieved from https://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml
  • American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
  • Taipale, H., Mittendorfer-Rutz, E., Alexanderson, K., Majak, M., Mehtälä, J., Hoti, F., Jedenius, E., Enkusson, D., Leval, A., Sermon, J., & Tanskanen, A. (2020). Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophrenia Research, 215, 6–12. https://doi.org/10.1016/j.schres.2019.11.030
  • Nemani, K., Li, C., Olfson, M., & Blessing, E. M. (2021). COVID-19 infection and psychiatric hospitalization risk in patients with schizophrenia: A retrospective cohort study. Journal of Clinical Psychiatry, 82(4), e20l13613. https://doi.org/10.4088/JCP.20l13613
  • Schizophrenia Research. "Cognitive Behavioural Therapy for Psychosis: A Systematic Review and Meta-analysis." https://www.sciencedirect.com/science/article/abs/pii/S0920996418303257

More Resources

see all